EUVIMEDEUVIMED entdecken
Crossref

Serum TCA cycle metabolites in Lewy bodies dementia and Alzheimer's disease: Network analysis and cognitive prognosis

Alberto Jaramillo-Jimenez, Lasse M Giil, Miguel Germán Borda, Diego A Tovar-Rios, Kåre Andre Kristiansen, Per Bruheim, Dag Aarsland, George E Barreto, Rolf Kristian Berge

Mitochondrion · 2023-07 · 71 · 17-25

DOI: 10.1016/j.mito.2023.05.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mitochondrion, 2023-07. Verfasst von Alberto Jaramillo-Jimenez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway; Faculty of Health Sciences, University of Stavanger, Stava…. Hauptthemen laut MEDLINE: Alzheimer Disease, Lewy Body Disease, Dementia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Department of Health, Center for Innovative Medicine, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormalities in the Tri-Carboxylic-Acid (TCA) cycle have been documented in dementia. Through network analysis, TCA cycle metabolites could indirectly reflect known dementia-related abnormalities in biochemical pathways, and key metabolites might be associated with prognosis. This study analyzed TCA cycle metabolites as predictors of cognitive decline in a mild dementia cohort and explored potential interactions with the diagnosis of Lewy Body Dementia (LBD) or Alzheimer's Disease (AD) and APOE-ε4 genotype. We included 145 mild dementia patients (LBD = 59; AD = 86). Serum TCA cycle metabolites were analyzed at baseline, and partial correlation networks were conducted. Cognitive performance was measured annually over 5-years with the Mini-mental State Examination. Longitudinal mixed-effects Tobit models evaluated each baseline metabolite as a predictor of 5-years cognitive decline. APOE-ε4 and diagnosis interactions were explored. Results showed comparable metabolite concentrations in LBD and AD. Multiple testing corrected networks showed larger coefficients for a negative correlation between pyruvate - succinate and positive correlations between fumarate - malate and citrate - Isocitrate in both LBD and AD. In the total sample, adjusted mixed models showed significant associations between baseline citrate concentration and longitudinal MMSE scores. In APOE-ε4 carriers, baseline isocitrate predicted MMSE scores. We conclude that, in mild dementia, serum citrate concentrations could be associated with subsequent cognitive decline, as well as isocitrate concentrations in APOE-ε4 carriers. Downregulation of enzymatic activity in the first half of the TCA cycle (decarboxylating dehydrogenases), with upregulation in the latter half (dehydrogenases only), might be indirectly reflected in serum TCA cycle metabolites' networks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseLewy Body DiseaseDementiaHumansIsocitratesLewy BodiesCarboxylic AcidsApolipoproteins EOxidoreductasesCognition

Stichwörter der Autor:innen

Alzheimer's diseaseCitric acid cycleCognitive declineDementiaDementia with Lewy bodies

Substanzen

isocitric acidIsocitratesCarboxylic AcidsApolipoproteins EOxidoreductases

Autor:innen und Institutionen

  • Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway; Faculty of Health Sciences, University of Stavanger, Stavanger, Norway; Grupo de Neurociencias de Antioquia, Universidad de Anti…
  • Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.
  • Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway; Faculty of Health Sciences, University of Stavanger, Stavanger, Norway; Semillero de Neurociencias y Envejecimiento, Ageing Inst…
  • Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway; Faculty of Health Sciences, University of Stavanger, Stavanger, Norway; Universidad Del Valle, Grupo de Investigación en Estadís…
  • Department of Biotechnology and Food Science, Norwegian University of Science and Technology, Trondheim, Norway.
  • Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway; Faculty of Health Sciences, University of Stavanger, Stavanger, Norway; Department of Old Age Psychiatry, Institute of Psychiatr…

Förderung

  • Department of Health
  • Center for Innovative Medicine
  • National Institute for Health and Care Research
  • King's College London

Zitieren

APA

Jaramillo-Jimenez, A., Giil, L. M., Borda, M. G., Tovar-Rios, D. A., Kristiansen, K. A., Bruheim, P., Aarsland, D., Barreto, G. E., & Berge, R. K. (2023). Serum TCA cycle metabolites in Lewy bodies dementia and Alzheimer's disease: Network analysis and cognitive prognosis. Mitochondrion, 71, 17-25. https://doi.org/10.1016/j.mito.2023.05.002

Vancouver

Jaramillo-Jimenez A, Giil LM, Borda MG, Tovar-Rios DA, Kristiansen KA, Bruheim P, et al. Serum TCA cycle metabolites in Lewy bodies dementia and Alzheimer's disease: Network analysis and cognitive prognosis. Mitochondrion. 2023;71:17-25. doi:10.1016/j.mito.2023.05.002

BibTeX
@article{JaramilloJimenez2023,
  author = {Jaramillo-Jimenez, Alberto and Giil, Lasse M and Borda, Miguel Germán and Tovar-Rios, Diego A and Kristiansen, Kåre Andre and Bruheim, Per and Aarsland, Dag and Barreto, George E and Berge, Rolf Kristian},
  title = {Serum TCA cycle metabolites in Lewy bodies dementia and Alzheimer's disease: Network analysis and cognitive prognosis},
  journal = {Mitochondrion},
  year = {2023},
  volume = {71},
  pages = {17--25},
  doi = {10.1016/j.mito.2023.05.002}
}
Kostenlos starten →